OcuZole Capsule (Omeprazole)

Adult dose

1) Gastric ulcer: Administer omeprazole 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is not complete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, a dose of 40mg once daily generally results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 2) Short-term treatment of duodenal ulcer: Administer 20mg orally once daily. Most cases may heal within 2 weeks, although the healing period may vary among patients. If healing is not complete after the initial 2 weeks of treatment, continue treatment for an additional 2 weeks. In patients who have not responded to other medicines, a dose of 40mg once daily generally results in healing within 4 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 3) Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is not complete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other medicines, a dose of 40mg once daily generally results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 4) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment with the dose individually adjusted as appropriate. More than 90% of patients respond to doses of 20 - 120mg daily. If a dose of 80mg or more per day is administered, divide the daily dose into 2 doses. 5) Maintenance treatment of severe reflux esophagitis and peptic ulcers that are difficult to treat: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 6) Combination therapy with antibiotics to prevent recurrence of duodenal ulcers infected with Helicobacter pylori: - Dual therapy: Administer this medicine 20mg and amoxicillin 750 - 1000mg twice daily for 2 weeks. - Triple therapy: Administer this medicine 40mg once daily or 20mg twice daily in combination with the following antibiotics. ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment effect is insufficient, omeprazole monotherapy may be continued. 7) Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Healing is generally possible after 2-4 weeks of treatment. 8) Treatment of gastric or duodenal ulcers or erosions caused by administration of nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is not complete after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. 9) Maintenance therapy for prevention of gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID administration in patients receiving long-term NSAID treatment who have a history of gastric or duodenal lesions: Administer 20mg orally once daily. * Take this medicine whole with at least half a glass of water. Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients who are allergic to its components. Caution should be taken in administering this medication to gastric ulcer patients suspected of having malignant tumors, as it may mask symptoms and delay diagnosis. Additionally, it should be avoided in patients taking specific antiviral agents such as atazanavir or rilpivirine. Patients with impaired liver function or the elderly should have their doses adjusted or be administered with caution. Various side effects such as headache, drowsiness, dizziness, dyspepsia, skin rashes may occur, and any unusual symptoms should be reported to healthcare professionals immediately. Long-term use may increase the risk of fracture, hypomagnesemia, and vitamin B12 malabsorption, thus regular check-ups are necessary. Long-term use of this medication may slightly increase the risk of gastrointestinal bacterial infections, so if diarrhea persists, consult a doctor. It may interact with other medications, particularly anticoagulants, anticonvulsants, and immunosuppressants, so it is essential to inform healthcare professionals if these medications are being taken. Women who are pregnant or breastfeeding should carefully consider the risks and benefits before using this medication, and it is recommended to avoid it if possible. It is recommended not to use in children as safety has not been established. In case of overdose, symptoms such as vomiting, diarrhea, and headache may occur, so immediate medical attention is necessary. This medication should be stored out of reach of children and should not be transferred to another container; after use, the cap should be tightly closed.

Headache, drowsiness, dizziness, insomnia, paresthesia, feeling faint, vertigo, confusion, agitation, aggressiveness, hallucinations, depression, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, interstitial nephritis, diarrhea, abdominal pain, constipation, nausea, vomiting, abdominal pain, abdominal distension, dry mouth, stomatitis, gastrointestinal candidiasis, erythema, rash, urticarial, itching, dermatitis, vesicular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, photosensitivity, alopecia, angioedema, fever, bronchospasm, interstitial nephritis, anaphylactic shock, chest pain, tachycardia, bradycardia, palpitations, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, back pain, arthralgia, muscle weakness, myalgia, gynecomastia, cough, asthenia, malaise, peripheral edema, increased sweating, blurred vision, visual impairment, taste disturbance, mastalgia, breast lump, hyponatremia, erectile dysfunction, Clostridium difficile-associated diarrhea, hypomagnesemia, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, systemic lupus erythematosus, discoid lupus erythematosus, gastric polyp, hypocalcemia, hypokalemia

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept away from extreme temperatures, ideally at room temperature between 1 and 30 degrees Celsius.

Appearance

A hard capsule with a brown upper part and a reddish lower part filled with yellowish enteric-coated granules.

Package unit

28 capsules/bottle